National audit of citrate toxicity in plateletpheresis donors

Transfusion Medicine

Volumn 12, Issue 3, 2002, Pages 187-191

  Makar, Y F ^a   Butler, M O ^a   Cockersole, G M ^a   Gabra, G ^b   Serevitch, J M ^a  

^a Manchester Blood Centre   (United Kingdom)

^b Birmingham Blood Centre   (United Kingdom)

Author keywords

Cell separator; Citrate toxicity; Plateletpheresis

Indexed keywords

CITRIC ACID;

ARTICLE; BLOOD DONOR; CELL SEPARATION; CLINICAL FEATURE; DEVICE; DISEASE SEVERITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; METHODOLOGY; NEEDLE; PARESTHESIA; SAFETY; STANDARD; SYMPTOM; SYNCOPE; THROMBOCYTOPHERESIS; UNITED KINGDOM; BLOOD BANK; MEDICAL AUDIT;

BLOOD BANKS; BLOOD DONORS; CITRIC ACID; GREAT BRITAIN; HUMANS; INCIDENCE; MEDICAL AUDIT; PLATELETPHERESIS;

EID: 0036082484     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.2002.00372.x     Document Type: Article

References (12)

1. Adverse events in platelet apheresis donors: A multivariate analysis in a hospital based programme
2. Citrate toxicity during massive blood transfusion
3. Dosage regimens for citrate anticoagulant
4. Citrate anticoagulants for plateletpheresis
5. Relationship of physical symptoms, ECG, free calcium and other blood chemistries in reinfusion with citrated blood
6. Frequency of immediate adverse effects associated with therapeutic apheresis
7. Donor reactions and injuries from whole blood donation
8. Laboratory and clinical effects of the infusion of ACD solution during plateletpheresis
9. Calcium homeostasis during therapeutic plasma exchange
10. Mechanisms of adverse effects during apheresis
11. Ionized calcium during plateletpheresis
12. Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluid